PCV31 HEALTH ECONOMIC ASSESSMENT OF RAISING HDL-C WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) WHEN ADDED TO STATIN THERAPY IN PATIENTS WITH DYSLIPIDEMIA AND TYPE 2 DIABETES-AN ANALYSIS FOR SWEDEN
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63647-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)63647-9/fulltext
Title :
PCV31 HEALTH ECONOMIC ASSESSMENT OF RAISING HDL-C WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) WHEN ADDED TO STATIN THERAPY IN PATIENTS WITH DYSLIPIDEMIA AND TYPE 2 DIABETES-AN ANALYSIS FOR SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63647-9&doi=10.1016/S1098-3015(10)63647-9
First page :
Section Title :
Open access? :
No
Section Order :
498